biotechnology, $ billion was invested in deals and, in life sciences overall, $ billion in deals (including biotechnology and medical devices). two thirds ( %) of the investment in biotechnology went to first-time/early-stage development deals and the remainder to the expansion stage of development ( %), seed-stage...
parallel to the cost of feeding and transporting them, whereas they (the live animals) fetch lower prices on the middle east markets due to poor quality and weak sanitary and phytosanitary situations. trade operators lack access to important market decision-support information such as market trends, at...